Study areas
Guidance by service line for healthcare professionals and referred patients.
- Pharmacogenomics: genetic variants and drug responsePharmacogenomics analyses variants in genes linked to absorption, distribution, metabolism and excretion of medicines. It may help guide drug choice or dose according to clinical guidelines. It does not replace medical judgement and must not lead to changing treatment without professional supervision.
- Clinical genetics: single-gene testsSingle-gene clinical genetics studies specific genes linked to known conditions. Methods may include Sanger sequencing, targeted NGS, genotyping or triplet-repeat expansion analysis. Indication, consent and genetic counselling, where required, are set by the healthcare professional.
- Pathology-oriented genetic profilesGenetic profiles in the catalogue group genes relevant to a specific condition or clinical trait, with narrower scope than NGS risk panels in the same line. They list associated variants. They do not establish a diagnosis or an individual predictive value for complex traits. Interpretation belongs to qualified staff.
- BrainGenomarkers · NeurologyBrainGenomarkers · Neurology groups genetic susceptibility panels for nervous-system disorders. They cover neurodegenerative, cerebrovascular and neurodevelopmental axes. They list associated variants; they do not diagnose on their own. Indication and interpretation belong to the healthcare professional.
- BrainGenomarkers · PsychiatryBrainGenomarkers · Psychiatry brings together genetic susceptibility panels for psychiatric disorders, including depression and schizophrenia. They list variants associated with complex traits. They do not establish a diagnosis or predict individual clinical course. Interpretation belongs to qualified staff.
- CardioGenomarkers: cardiology and metabolismCardioGenomarkers groups genetic susceptibility panels for cardiomyopathies, arrhythmias and cardiometabolic disorders such as diabetes, obesity and hypertension. Narrower profiles also appear under genetic profiles. They do not replace clinical cardiology assessment.
- OncoGenomarkers: hereditary cancer susceptibilityOncoGenomarkers brings together panels of hereditary genetic susceptibility to different oncological conditions. The catalogue includes, among others, breast and ovary, colorectal, prostate, lung, melanoma and hereditary leukaemia or myelodysplastic syndromes. Indication is set by the professional.
- Nutrigenomics: genetic variants and nutritionNutrigenomics studies genetic variants related to nutrient response, body weight and food intolerances. It may help guide personalised nutrition plans with a professional. Alone it is not a dietary recommendation. The panel GLP-1 block is pharmacogenetics of a prescription medicine.
- Next-generation sequencing (NGS)Next-generation sequencing (NGS) can study many genes or nearly the whole genome in one assay. The catalogue describes exome, whole genome and high-coverage panels, including structural variants and CNV detection when the method supports it. Broad sequencing can generate unsolicited findings.
- Genetics and reproduction: infertilityThis area groups, for information purposes, catalogue genetic studies oriented to female and male infertility. They are NGS panels of genes associated with fertility impairment. They do not replace clinical reproductive assessment and do not set an assisted-reproduction plan on their own.
- Multi-omics: transcriptomics, epigenetics, proteomics and metabolomicsMulti-omics extends genomics with layers of gene expression, epigenetic regulation, proteins and metabolites. In the catalogue, transcriptomics and epigenetics (methylome) are available by clinical area; proteomics and metabolomics are listed as coming soon. They do not replace the clinical phenotype.
